These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2291980)

  • 1. Why clinicians should be interested in interleukin-3.
    Valent P; Geissler K; Sillaber C; Lechner K; Bettelheim P
    Blut; 1990 Dec; 61(6):338-45. PubMed ID: 2291980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
    Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W
    Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-3. Its biology and potential uses in pediatric hematology/oncology.
    Sunderland MC; Roodman GD
    Am J Pediatr Hematol Oncol; 1991; 13(4):414-25. PubMed ID: 1785668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP; Jacobsen FW; Cui L; Lyman SD; Jacobsen SE
    J Immunol; 1996 Oct; 157(7):2953-60. PubMed ID: 8816402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hemopoietic stem cells in liquid culture.
    Ploemacher RE; van Soest PL; Voorwinden H; Boudewijn A
    Leukemia; 1993 Sep; 7(9):1381-8. PubMed ID: 7690440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.
    Warren DJ; Moore MA
    J Immunol; 1988 Jan; 140(1):94-9. PubMed ID: 3257232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
    Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular biology of interleukin-3.
    Morris CF; Young IG; Hapel AJ
    Immunol Ser; 1990; 49():177-214. PubMed ID: 2090251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukin-3: a preclinical study].
    Valent P; Geissler K; Bettelheim P
    Wien Klin Wochenschr; 1989 Oct; 101(19):652-63. PubMed ID: 2482586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
    Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.
    Yamaguchi Y; Suda T; Suda J; Eguchi M; Miura Y; Harada N; Tominaga A; Takatsu K
    J Exp Med; 1988 Jan; 167(1):43-56. PubMed ID: 3257253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of haematopoietic progenitor development by FLT-3 ligand.
    Banu N; Deng B; Lyman SD; Avraham H
    Cytokine; 1999 Sep; 11(9):679-88. PubMed ID: 10479404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.